Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""SALVAGE therapy"" wg kryterium: Temat


Tytuł:
Post-prostatectomy radiotherapy: does late toxicity lead the game?
Autorzy:
De Meerleer G; Department of Radiation Oncology, Leuven University Hospital, Leuven, Belgium.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2022 Dec; Vol. 130 (6), pp. 705-707.
Typ publikacji:
Editorial
MeSH Terms:
Prostatectomy*/adverse effects
Radiotherapy, Intensity-Modulated*
Male ; Humans ; Radiotherapy Dosage ; Salvage Therapy ; Radiotherapy, Adjuvant/adverse effects
Opinia redakcyjna
Tytuł:
Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience.
Autorzy:
Murgic J; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia.
Jaksic B; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia.
Prpic M; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia.; School of Dental Medicine, University of Zagreb, Gunduliceva 5, 10000, Zagreb, Croatia.
Kust D; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia.
Bahl A; University Hospitals Bristol NHS Foundation Trust, Marlborough Street, Bristol, BS13NU, UK.
Budanec M; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia.
Prgomet Secan A; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia.
Franco P; Department of Translational Medicine, University of Eastern Piedmont, 28100, Novara, Italy.; Department of Radiation Oncology, 'Maggiore della Carità' University Hospital, 28100, Novara, Italy.
Kruljac I; Department of Endocrinology, Diabetes and Metabolic Diseases 'Mladen Sekso', University Hospital Center Sestre Milosrdnice, University of Zagreb School of Medicine, Vinogradska 29, 10000, Zagreb, Croatia.
Spajic B; Department of Urology, University Hospital Center Sestre Milosrdnice, 10000, Zagreb, Croatia.
Babic N; Department of Radiology, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia.
Kruslin B; Ljudevit Jurak Department of Pathology and Cytology, Sestre Milosrdnice University Hospital Centre, Vinogradska 29, 10000, Zagreb, Croatia.
Zovak M; Department of Surgery, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia.
Zubizarreta E; Division of Human Health, International Atomic Energy Agency (IAEA), Wagramer Str. 5, 1220, Vienna, Austria.
Rosenblatt E; Division of Human Health, International Atomic Energy Agency (IAEA), Wagramer Str. 5, 1220, Vienna, Austria.
Fröbe A; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia. .; School of Dental Medicine, University of Zagreb, Gunduliceva 5, 10000, Zagreb, Croatia. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2021 May 12; Vol. 16 (1), pp. 88. Date of Electronic Publication: 2021 May 12.
Typ publikacji:
Clinical Trial; Comparative Study; Journal Article
MeSH Terms:
Dose Fractionation, Radiation*
Radiation Dose Hypofractionation*
Salvage Therapy*
Prostate-Specific Antigen/*blood
Prostatectomy/*mortality
Prostatic Neoplasms/*mortality
Radiotherapy, Intensity-Modulated/*mortality
Aged ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/mortality ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/radiotherapy ; Neoplasm Recurrence, Local/surgery ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/radiotherapy ; Prostatic Neoplasms/surgery ; Radiotherapy, Intensity-Modulated/methods ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Salvage open radical prostatectomy for recurrent prostate cancer following MRI-guided transurethral ultrasound ablation (TULSA) of the prostate: feasibility and efficacy.
Autorzy:
Nair SM; Division of Urology, Department of Surgery, Western University, London, ON, Canada.
Stern N; Division of Urology, Department of Surgery, Western University, London, ON, Canada.
Dewar M; Life Kingsbury Hospital, Cape Town, South Africa.
Siddiqui K; Department of Surgery, Sultan Qaboos University Hospital, Muscat, Oman.
Smith E; University of Toronto, Toronto, ON, Canada.
Gomez JA; Department of Pathology, Western University, London, ON, Canada.
Moussa M; Department of Pathology, Western University, London, ON, Canada.
Chin JL; Division of Urology, Department of Surgery, Western University, London, ON, Canada.
Pokaż więcej
Źródło:
Scandinavian journal of urology [Scand J Urol] 2020 Jun; Vol. 54 (3), pp. 215-219. Date of Electronic Publication: 2020 Apr 20.
Typ publikacji:
Journal Article
MeSH Terms:
Magnetic Resonance Imaging*
Salvage Therapy*
Ultrasonic Surgical Procedures*/methods
Neoplasm Recurrence, Local/*surgery
Prostatectomy/*methods
Prostatic Neoplasms/*surgery
Ablation Techniques ; Aged ; Feasibility Studies ; Humans ; Male ; Surgery, Computer-Assisted ; Treatment Outcome ; Urethra
Czasopismo naukowe
Tytuł:
PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial.
Autorzy:
De Bruycker A; Department of Radiation oncology and experimental cancer research, Ghent University Hospital, Ghent, Belgium.
Spiessens A; Department of Radiation oncology and experimental cancer research, Ghent University Hospital, Ghent, Belgium.
Dirix P; Department of Radiation oncology, Iridium Cancer Network, GZ Antwerp, Antwerp, Belgium.
Koutsouvelis N; Department of Radiation oncology, Geneva University Hospital, Geneva, Switzerland.
Semac I; Department of Radiation oncology, Geneva University Hospital, Geneva, Switzerland.; Clinical Research Center, Geneva University Hospital and Faculty of Medicine, Geneva, Switzerland.
Liefhooghe N; Department of Radiation oncology, AZ Groeninge, Kortrijk, Belgium.
Gomez-Iturriaga A; Cruces University Hospital (Biocruces Health Research Institute), Barakaldo, Spain.
Everaerts W; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
Otte F; Department of Radiation oncology, Jules Bordet Institute and Hôpital Erasme, University Clinics of Brussels, Université Libre de Bruxelles, Brussels, Belgium.
Papachristofilou A; Clinic of Radiotherapy & Radiation Oncology, University Hospital Basel, Basel, Switzerland.
Scorsetti M; Humanitas Clinical and Research Hospital, IRCSS, Radiotherapy and Radiosurgery Department, Rozzano, Milan, Italy.
Shelan M; Department of Radiation oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Siva S; Epworth Healthcare, University of Melbourne, Melbourne, Australia.
Ameye F; Department of Urology, AZ Maria-Middelares Ghent, Ghent, Belgium.
Guckenberger M; Department of Radiation Oncology, University Hospital Zürich, University of Zurich, Zürich, Switzerland.
Heikkilä R; Department of Oncology, Oslo University Hospital, Oslo, Norway.
Putora PM; Department of Radiation oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department of Radiation Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Zapatero A; University Hospital La Princesa, Madrid, Spain.
Conde-Moreno A; Department of Radiation oncology, Hospital Universitari i Politècnic la Fe, Valencia, Spain.
Couñago F; Department of Radiation oncology, University Hospital of Quirón, Madrid, Spain.
Vanhoutte F; Department of Radiation oncology and experimental cancer research, Ghent University Hospital, Ghent, Belgium.
Goetghebeur E; Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium.
Reynders D; Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium.
Zilli T; Department of Radiation oncology, Geneva University Hospital, Geneva, Switzerland. .
Ost P; Department of Radiation oncology and experimental cancer research, Ghent University Hospital, Ghent, Belgium. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2020 May 12; Vol. 20 (1), pp. 406. Date of Electronic Publication: 2020 May 12.
Typ publikacji:
Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Quality of Life*
Salvage Therapy*
Androgen Antagonists/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Neoplasm Recurrence, Local/*therapy
Prostatectomy/*mortality
Prostatic Neoplasms/*therapy
Radiosurgery/*mortality
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Combined Modality Therapy ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Prospective Studies ; Prostatic Neoplasms/secondary ; Survival Rate ; Young Adult
Czasopismo naukowe
Tytuł:
Clinical outcomes of salvage treatment in lymph node-positive prostate cancer patients after radical prostatectomy.
Autorzy:
Kim D; Department of Radiation Oncology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
Kim DY; Department of Radiation Oncology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
Kim JS; Department of Radiation Oncology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.
Hong SK; Department of Urology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.
Byun SS; Department of Urology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.
Lee SE; Department of Urology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Sep 10; Vol. 16 (9), pp. e0256778. Date of Electronic Publication: 2021 Sep 10 (Print Publication: 2021).
Typ publikacji:
Journal Article
MeSH Terms:
Combined Modality Therapy/*methods
Neoplasm Recurrence, Local/*pathology
Prostatectomy/*adverse effects
Prostatic Neoplasms/*surgery
Salvage Therapy/*methods
Aged ; Aged, 80 and over ; Humans ; Lymph Nodes/drug effects ; Lymph Nodes/pathology ; Male ; Middle Aged ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Early Experience with Salvage Robotic-Assisted Radical Prostatectomy in Proton Beam Radiotherapy Failures.
Autorzy:
Bozkurt Y; Department of Urology, İstinye University, İstanbul, Turkey.
Atar M; Department of Urology, Bower Hospital, Diyarbakır, Turkey.
Pisters LL; Department of Urology, University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło:
Balkan medical journal [Balkan Med J] 2021 Sep; Vol. 38 (5), pp. 310-315.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms*/pathology
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/surgery
Robotic Surgical Procedures*/methods
Robotics*
Lymph Node Excision/*methods
Neoplasm Recurrence, Local/*surgery
Prostatectomy/*methods
Salvage Therapy/*methods
Aged ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Prostate-Specific Antigen/blood ; Protons ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Adjuvant vs. salvage Radiation Therapy after Radical Prostatectomy: Role of Decipher® in the Era of Personalized Medicine.
Autorzy:
Nowroozi A; Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran. .
Karimi A; Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran. .
Alilou S; Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran. .
Amini E; Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran. .
Pokaż więcej
Źródło:
Urology journal [Urol J] 2021 Jan 10; Vol. 18 (3), pp. 349-350. Date of Electronic Publication: 2021 Jan 10.
Typ publikacji:
Comparative Study; Letter
MeSH Terms:
Precision Medicine*
Prostatectomy*/methods
Prostatic Neoplasms/*genetics
Prostatic Neoplasms/*radiotherapy
Genomics ; Humans ; Male ; Prostatic Neoplasms/classification ; Prostatic Neoplasms/surgery ; Radiotherapy, Adjuvant ; Risk Assessment ; Salvage Therapy
Raport
Tytuł:
Nerve-sparing in salvage robot-assisted prostatectomy: surgical technique, oncological and functional outcomes at a single high-volume institution.
Autorzy:
Bonet X; Hospital Universitari de Bellvitge, Barcelona, Spain.; Global Robotic Institute, Florida Hospital, Celebration, FL, USA.
Ogaya-Pinies G; Global Robotic Institute, Florida Hospital, Celebration, FL, USA.
Woodlief T; Global Robotic Institute, Florida Hospital, Celebration, FL, USA.
Hernandez-Cardona E; Global Robotic Institute, Florida Hospital, Celebration, FL, USA.
Ganapathi H; Global Robotic Institute, Florida Hospital, Celebration, FL, USA.
Rogers T; Global Robotic Institute, Florida Hospital, Celebration, FL, USA.
Coelho RF; Global Robotic Institute, Florida Hospital, Celebration, FL, USA.; University of Sao Paulo School of Medicine, Sao Paulo, Brazil.
Rocco B; Global Robotic Institute, Florida Hospital, Celebration, FL, USA.; Fondazione IRCCS Ca' Grande Ospedale Maggiore Policlinico, Milan, Italy.
Vigués F; Hospital Universitari de Bellvitge, Barcelona, Spain.
Patel V; Global Robotic Institute, Florida Hospital, Celebration, FL, USA.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2018 Nov; Vol. 122 (5), pp. 837-844. Date of Electronic Publication: 2018 Sep 14.
Typ publikacji:
Journal Article
MeSH Terms:
Organ Sparing Treatments*/adverse effects
Organ Sparing Treatments*/methods
Organ Sparing Treatments*/statistics & numerical data
Prostatectomy*/adverse effects
Prostatectomy*/methods
Prostatectomy*/statistics & numerical data
Robotic Surgical Procedures*/adverse effects
Robotic Surgical Procedures*/methods
Robotic Surgical Procedures*/statistics & numerical data
Salvage Therapy*/adverse effects
Salvage Therapy*/methods
Salvage Therapy*/statistics & numerical data
Prostatic Neoplasms/*surgery
Erectile Dysfunction/epidemiology ; Erectile Dysfunction/etiology ; Humans ; Kaplan-Meier Estimate ; Male ; Postoperative Complications/epidemiology ; Prostate/innervation ; Prostate/surgery ; Prostatic Neoplasms/mortality ; Retrospective Studies ; Treatment Outcome ; Urinary Incontinence/epidemiology ; Urinary Incontinence/etiology
Czasopismo naukowe
Tytuł:
Outcomes of salvage radical prostatectomy following more than one failed local therapy.
Autorzy:
Sivaraman A; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Scardino P; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Eastham J; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Pokaż więcej
Źródło:
Investigative and clinical urology [Investig Clin Urol] 2018 May; Vol. 59 (3), pp. 152-157. Date of Electronic Publication: 2018 Mar 20.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatectomy*/adverse effects
Salvage Therapy*
Neoplasm Recurrence, Local/*surgery
Prostatic Neoplasms/*therapy
Aged ; Blood Loss, Surgical ; Cryosurgery ; Humans ; Male ; Middle Aged ; Operative Time ; Postoperative Complications/surgery ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/pathology ; Radiotherapy ; Reoperation ; Treatment Failure
Czasopismo naukowe
Tytuł:
Ga-PSMA-PET/CT helps to select patients for salvage radical prostatectomy with local recurrence after primary radiotherapy for prostate cancer.
Autorzy:
Pfister D; Department of Urology, Uro-Oncology and Robot Assisted Surgery, University Hospital of Cologne, Cologne, Germany.
Haidl F; Department of Urology, Uro-Oncology and Robot Assisted Surgery, University Hospital of Cologne, Cologne, Germany.
Nestler T; Department of Urology, Uro-Oncology and Robot Assisted Surgery, University Hospital of Cologne, Cologne, Germany.
Verburg F; Department of Radiation and Nuclear Medicine, ErasmusMC, Rotterdam, Netherlands.
Schmidt M; Department of Nuclear Medicine, University of Cologne, Köln, Germany.
Wittersheim M; Institute for Pathology, University Hospital of Cologne, Cologne, Germany.
Steib F; Institute of Pathologie, University Hospital of Aachen, Aachen, Germany.
Heidenreich A; Department of Urology, Uro-Oncology and Robot Assisted Surgery, University Hospital of Cologne, Cologne, Germany.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2020 Dec; Vol. 126 (6), pp. 679-683. Date of Electronic Publication: 2020 Aug 04.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/pathology
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/surgery
Edetic Acid/*analogs & derivatives
Oligopeptides/*therapeutic use
Positron Emission Tomography Computed Tomography/*methods
Prostatectomy/*methods
Salvage Therapy/*methods
Aged ; Edetic Acid/therapeutic use ; Gallium Isotopes ; Gallium Radioisotopes ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/surgery ; Prostate/diagnostic imaging ; Prostate/pathology ; Prostate/surgery
Czasopismo naukowe
Tytuł:
Rates of primary and secondary treatments for patients on active surveillance for localized prostate cancer-A population-based cohort study.
Autorzy:
Matta R; Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
Hird AE; Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
Dvorani E; Institute of Clinical Evaluative Sciences, University of Toronto, Toronto, ON, Canada.
Saskin R; Institute of Clinical Evaluative Sciences, University of Toronto, Toronto, ON, Canada.
Nason GJ; Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.; Division of Urology, University Health Network, University of Toronto, Toronto, ON, Canada.
Kulkarni G; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.; Division of Urology, University Health Network, University of Toronto, Toronto, ON, Canada.
Kodama RT; Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
Herschorn S; Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
Nam RK; Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2020 Oct; Vol. 9 (19), pp. 6946-6953. Date of Electronic Publication: 2020 Aug 05.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Androgen Antagonists/*therapeutic use
Practice Patterns, Physicians'/*trends
Prostatectomy/*trends
Prostatic Neoplasms/*therapy
Watchful Waiting/*trends
Aged ; Aged, 80 and over ; Androgen Antagonists/adverse effects ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Ontario/epidemiology ; Prostatectomy/adverse effects ; Prostatectomy/mortality ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/pathology ; Radiotherapy/trends ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Salvage Therapy/trends ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Early salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: Its impact and optimal candidate.
Autorzy:
Tomita N; Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
Uchiyama K; Department of Radiology, Kariya Toyota General Hospital, Kariya, Aichi, Japan.
Mizuno T; Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.; Department of Radiology, Kariya Toyota General Hospital, Kariya, Aichi, Japan.
Imai M; Department of Radiology, Nagoya Daini Red Cross Hospital, Nagoya, Aichi, Japan.
Sugie C; Department of Radiology, Nagoya Daini Red Cross Hospital, Nagoya, Aichi, Japan.
Ayakawa S; Department of Radiation Oncology, Chukyo Hospital, Nagoya, Aichi, Japan.
Niwa M; Department of Radiation Oncology, Suzuka General Hospital, Suzuka, Mie, Japan.
Matsui T; Department of Radiology, Konan Kosei Hospital, Konan, Aichi, Japan.
Otsuka S; Department of Radiology, Okazaki City Hospital, Okazaki, Aichi, Japan.
Manabe Y; Department of Radiation Oncology, Nanbu Tokushukai General Hospital, Shimajiri, Okinawa, Japan.
Nomura K; Department of Radiotherapy, Nagoya City West Medical Center, Nagoya, Aichi, Japan.
Kondo T; Department of Radiology, Narita Memorial Hospital, Toyohashi, Aichi, Japan.
Kosaki K; Department of Radiation Oncology, Kasugai Municipal Hospital, Kasugai, Aichi, Japan.
Miyakawa A; Department of Radiation Oncology, National Hospital Organization Nagoya Medical Center, Nagoya, Aichi, Japan.
Miyamoto A; Department of Radiation Oncology, Hokuto Hospital, Obihiro, Hokkaido, Japan.
Takemoto S; Department of Radiology, Fujieda Heisei Memorial Hospital, Fujieda, Shizuoka, Japan.
Yasui T; Department of Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
Shibamoto Y; Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
Pokaż więcej
Źródło:
Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2020 Aug; Vol. 16 (4), pp. 273-279. Date of Electronic Publication: 2020 Jun 09.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Prostatectomy/*methods
Prostatic Neoplasms/*radiotherapy
Salvage Therapy/*methods
Aged ; Aged, 80 and over ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/surgery ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł:
Can pelvic node dissection at radical prostatectomy influence the nodal recurrence at salvage lymphadenectomy for prostate cancer?
Autorzy:
Sivaraman A; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, NY, USA.
Benfante N; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, NY, USA.
Touijer K; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, NY, USA.
Coleman J; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, NY, USA.
Scardino P; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, NY, USA.
Laudone V; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, NY, USA.
Eastham J; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, NY, USA.
Pokaż więcej
Źródło:
Investigative and clinical urology [Investig Clin Urol] 2018 Mar; Vol. 59 (2), pp. 83-90. Date of Electronic Publication: 2018 Feb 22.
Typ publikacji:
Journal Article
MeSH Terms:
Lymph Node Excision*/adverse effects
Lymph Node Excision*/methods
Lymph Nodes*/pathology
Lymph Nodes*/surgery
Neoplasm Recurrence, Local*/pathology
Neoplasm Recurrence, Local*/surgery
Prostatectomy*/adverse effects
Prostatectomy*/methods
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/pathology
Prostatic Neoplasms*/surgery
Salvage Therapy*/methods
Salvage Therapy*/statistics & numerical data
Humans ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Staging ; Outcome Assessment, Health Care ; Pelvis ; Prostate/pathology ; Prostate-Specific Antigen/analysis ; Retrospective Studies ; United States
Czasopismo naukowe
Tytuł:
Variation in adjuvant and early salvage radiotherapy after robot-assisted radical prostatectomy for prostate cancer: a population-based cohort study.
Autorzy:
Draulans C; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium.
Van Damme N; Belgian Cancer Registry, Brussels, Belgium.
Isebaert S; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium.
Everaerts W; Department of Urology, University Hospitals Leuven, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
Silversmit G; Belgian Cancer Registry, Brussels, Belgium.
Joniau S; Department of Urology, University Hospitals Leuven, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
De Meerleer G; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium.
Van Eycken E; Belgian Cancer Registry, Brussels, Belgium.
Haustermans K; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium.
Pokaż więcej
Corporate Authors:
Be-RALP: The Belgian RALP consortium
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2020 Aug; Vol. 59 (8), pp. 904-910.
Typ publikacji:
Journal Article
MeSH Terms:
Robotic Surgical Procedures*
Prostatectomy/*methods
Prostatic Neoplasms/*radiotherapy
Prostatic Neoplasms/*surgery
Salvage Therapy/*methods
Aged ; Belgium ; Cohort Studies ; Humans ; Male ; Middle Aged ; Odds Ratio ; Prospective Studies ; Prostatic Neoplasms/pathology ; Radiotherapy, Adjuvant ; Regression Analysis
Czasopismo naukowe
Tytuł:
Salvage radical prostatectomy following focal therapy: functional and oncological outcomes.
Autorzy:
Herrera-Caceres JO; Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, ON, Canada.
Nason GJ; Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, ON, Canada.
Salgado-Sanmamed N; Department of Radiation Oncology, University Health Network, University of Toronto, Toronto, ON, Canada.
Goldberg H; Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, ON, Canada.
Woon DTS; Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, ON, Canada.
Chandrasekar T; Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, ON, Canada.
Ajib K; Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, ON, Canada.
Tan GH; Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, ON, Canada.
Alhunaidi O; Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, ON, Canada.
van der Kwast T; Department of Pathology and Laboratory Medicine, University Health Network, University of Toronto, Toronto, ON, Canada.
Finelli A; Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, ON, Canada.
Zlotta AR; Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, ON, Canada.
Hamilton RJ; Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, ON, Canada.
Berlin A; Department of Radiation Oncology, University Health Network, University of Toronto, Toronto, ON, Canada.
Perlis N; Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, ON, Canada.
Fleshner NE; Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, ON, Canada.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2020 Apr; Vol. 125 (4), pp. 525-530. Date of Electronic Publication: 2020 Jan 09.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatectomy/*methods
Prostatic Neoplasms/*surgery
Aged ; Combined Modality Therapy ; Humans ; Male ; Middle Aged ; Prostatic Neoplasms/therapy ; Retrospective Studies ; Salvage Therapy ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Further evidence that surgery after focal therapy for prostate cancer is safe.
Autorzy:
Stonier T; St George's Hospital, London, UK.
Cathcart P; Guy's Hospital, London, UK.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2020 Apr; Vol. 125 (4), pp. 481-482.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Prostatectomy*
Prostatic Neoplasms/*surgery
Humans ; Male ; Salvage Therapy
Opinia redakcyjna
Tytuł:
Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study.
Autorzy:
Kim M; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Song C; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Jeong IG; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Choi SK; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Park M; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Shim M; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Kim YS; Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
You D; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Hong JH; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Kim CS; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Ahn H; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2018 Mar 09; Vol. 18 (1), pp. 271. Date of Electronic Publication: 2018 Mar 09.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatectomy*
Salvage Therapy*
Androgen Antagonists/*therapeutic use
Neoplasm Recurrence, Local/*drug therapy
Prostatic Neoplasms/*drug therapy
Aged ; Case-Control Studies ; Combined Modality Therapy ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/therapy ; Prognosis ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/therapy ; Radiotherapy Dosage ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł:
Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomy.
Autorzy:
Tilki D; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.; Departments of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Preisser F; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Tennstedt P; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Tober P; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Mandel P; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.; Departments of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Schlomm T; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.; Departments of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Steuber T; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Huland H; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Schwarz R; Radiation Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Petersen C; Radiation Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Graefen M; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Ahyai S; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.; Departments of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2017 May; Vol. 119 (5), pp. 717-723. Date of Electronic Publication: 2016 Nov 21.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Prostatectomy*/methods
Salvage Therapy*
Prostatic Neoplasms/*radiotherapy
Prostatic Neoplasms/*surgery
Aged ; Combined Modality Therapy ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/blood ; Neoplasm Staging ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/pathology ; Radiotherapy, Adjuvant ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Stereotactic radiotherapy for prostate bed recurrence after prostatectomy, a multicentric series.
Autorzy:
Francolini G; Radiation Oncology Unit, University of Florence, Florence, Italy.; CyberKnife Center, L'Istituto Fiorentino di Cura e Assistenza (IFCA), Florence, Italy.
Jereczek-Fossa BA; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.; Division of Radiotherapy, European Institute of Oncology (IEO), L'Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
Di Cataldo V; Radiation Oncology Unit, University of Florence, Florence, Italy.; CyberKnife Center, L'Istituto Fiorentino di Cura e Assistenza (IFCA), Florence, Italy.
Simontacchi G; Radiation Oncology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Marvaso G; Division of Radiotherapy, European Institute of Oncology (IEO), L'Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
Zerella MA; Division of Radiotherapy, European Institute of Oncology (IEO), L'Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
Gentile P; University of Pittsburgh Medical Center (UPMC) San Pietro Fatebenefratelli (FBF), Rome, Italy.
Bianciardi F; University of Pittsburgh Medical Center (UPMC) San Pietro Fatebenefratelli (FBF), Rome, Italy.
Allegretta S; University of Pittsburgh Medical Center (UPMC) San Pietro Fatebenefratelli (FBF), Rome, Italy.
Detti B; Radiation Oncology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Masi L; Department of Medical Physics and Radiation Oncology, IFCA, Florence, Italy.
Lo Russo M; Radiation Oncology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Livi L; Department of Biomedical, Experimental, and Clinical Sciences 'Mario Serio', University of Florence, Florence, Italy.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2020 Mar; Vol. 125 (3), pp. 417-425. Date of Electronic Publication: 2019 Nov 15.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Prostatectomy*
Radiosurgery*/adverse effects
Neoplasm Recurrence, Local/*radiotherapy
Prostatic Neoplasms/*radiotherapy
Prostatic Neoplasms/*surgery
Aged ; Humans ; Male ; Retrospective Studies ; Salvage Therapy ; Treatment Outcome
Czasopismo naukowe
Tytuł:
The role of cystoprostatectomy in management of locally advanced prostate cancer: a systematic review.
Autorzy:
Yuan P; Department of Urology, Tongji Hospital, Tongji Medical School, Huazhong University of Science and Technology, Wuhan, China.
Wang S; Department of Urology, Tongji Hospital, Tongji Medical School, Huazhong University of Science and Technology, Wuhan, China.
Liu X; Department of Urology, Tongji Hospital, Tongji Medical School, Huazhong University of Science and Technology, Wuhan, China.
Wang X; Department of Urology, Tongji Hospital, Tongji Medical School, Huazhong University of Science and Technology, Wuhan, China.
Ye Z; Department of Urology, Tongji Hospital, Tongji Medical School, Huazhong University of Science and Technology, Wuhan, China.
Chen Z; Department of Urology, Tongji Hospital, Tongji Medical School, Huazhong University of Science and Technology, Wuhan, China. urol_.
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2020 Jan 20; Vol. 18 (1), pp. 14. Date of Electronic Publication: 2020 Jan 20.
Typ publikacji:
Journal Article; Systematic Review
MeSH Terms:
Cystectomy*
Neoplasm Recurrence, Local*
Prostatectomy*
Prostatic Neoplasms/*surgery
Humans ; Male ; Margins of Excision ; Neoplasm Invasiveness ; Prognosis ; Progression-Free Survival ; Prostatic Neoplasms/pathology ; Quality of Life ; Salvage Therapy ; Survival Rate ; Urinary Bladder/pathology ; Urinary Bladder/surgery
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies